BCT, breast-conserving therapy; IBC, inflammatory breast cancer; NAC, neoadjuvant chemotherapy; LABC, locally advanced breast cancer; HER2, human epidermal growth factor receptor-2; RCT, randomized controlled trial; SEER, Surveillance, Epidemiology, and End Results. The gene discussed is ERBB2; the disease is breast carcinoma.